Left Lateral Position and Supine Position in EUS-PPG Measurement
The Comparative Study on Left Lateral Position and Supine Position in Endoscopic Ultrasound Guided Portal Pressure Gradient Measurement
1 other identifier
observational
30
1 country
1
Brief Summary
The consistency of EUS-PPG measurements between left lateral decubitus and supine positions is unclear. In this prospective comparative study, we are aimed to evaluate the correlation between EUS-PPG measured in supine position (EUS-suPPG), and EUS-PPG measured in left lateral decubitus position (EUS-lePPG).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2025
CompletedFirst Posted
Study publicly available on registry
May 29, 2025
CompletedStudy Start
First participant enrolled
June 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 29, 2025
CompletedFebruary 6, 2026
May 1, 2025
7 months
May 20, 2025
February 4, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
EUS-lePPG
EUS-PPG measured in left lateral decubitus position
From the begining of zero calibration for pressure transducer to the end of the endoscopic procedure, until up to 1 day.
Study Arms (1)
EUS-suPPG
EUS-PPG measured in supine position
Interventions
Eligibility Criteria
Hospitalized patients with liver cirrhosis
You may qualify if:
- Hospitalized patients with liver cirrhosis, and are willing to sign the informed consent.
You may not qualify if:
- Unwilling to sign the informed consent
- Severe coagulopathy (INR\>1.6)
- Severe thrombocytopenia (platelets \<20,000/μL)
- Bacteremia
- Age\<18, or≥81
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The 2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, China
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2025
First Posted
May 29, 2025
Study Start
June 16, 2025
Primary Completion
December 29, 2025
Study Completion
December 29, 2025
Last Updated
February 6, 2026
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share